We found no evidence of FcεRI‐mediated activation of basophils or mast cell degranulation with hMOv18 IgE.14 However, the safety of hMOv18 IgE in a physiologically and immunologically relevant immunocompetent tumour‐bearing in vivo system has not yet been evaluated. The gene discussed is IGHE; the disease is neoplasm.